Tj. Montine et al., Endogenous brain catechol thioethers in dopaminergic neurodegeneration, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 155-166
Pathological and biochemical studies have consistently associated endogenou
s catechol oxidation with dopaminergic neurodegeneration in Parkinson's dis
ease (PD). Recently it has been proposed that products of catechol oxidatio
n, the catechol thioethers, may contribute to dopaminergic neurodegeneratio
n. In other organ systems, thioether cytotoxicity is influenced profoundly
by the mercapturic acid pathway. We have pursued the hypothesis that endoge
nous catechol thioethers produced in the mercapturic acid pathway contribut
e to dopaminergic neurodegeneration. Our results showed that in vitro metal
-catalyzed oxidative damage by catechol thioethers varied with the structur
es of the parent catechol and thioether adduct. Catechol mercapturates were
unique in producing more oxidative damage than their parent catechols. In
dopaminergic cell cultures, dopamine induced apoptosis in a concentration-d
ependent manner from 5 to 50 muM The apoptotic effect of dopamine was great
ly enhanced by subcytotoxic concentrations of the mitochondrial inhibitor,
N-methyl-4-phenylpyridinium (MPP+). Similarly, subcytotoxic levels of the m
ercapturate or homocysteine conjugate of dopamine significantly augmented d
opamine-induced apoptosis. Finally, microsomal fractions of substantia nigr
a from PD patients and age-matched controls had comparable cysteine-S-conju
gate N-acetyltransferase activity. These data indicate that the mercapturat
e conjugate of dopamine may augment dopaminergic neurodegeneration and that
the mercapturate pathway exists in human substantia nigra.